Bulletin
Investor Alert

press release

Nov. 1, 2021, 7:01 a.m. EDT

Apellis Pharmaceuticals to Host Conference Call on November 8, 2021 to Discuss Third Quarter 2021 Financial Results

WALTHAM, Mass., Nov 01, 2021 (GLOBE NEWSWIRE via COMTEX) -- WALTHAM, Mass., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals , Inc. /zigman2/quotes/202103251/composite APLS -4.21% , a global biopharmaceutical company and leader in targeted C3 therapies, today announced that the company will host a conference call and webcast to discuss its third quarter 2021 financial results on Monday, November 8, 2021 at 4:30 p.m. ET.

To access the live call by phone, please pre-register for the call here . The conference ID is 1931859. A live audio webcast of the event and accompanying slides may also be accessed through the "Events and Presentations" page of the "Investors and Media" section of the company's website . A replay of the webcast will be available for 90 days following the event.

About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in targeted C3 therapies, we aim to develop transformative therapies for a broad range of debilitating diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, nephrology, and neurology. For more information, please visit www.apellis.com .

Investor Contact:
Meredith Kaya
meredith.kaya@apellis.com
617.599.8178

COMTEX_396171924/2471/2021-11-01T07:00:42

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

(C) Copyright 2021 GlobeNewswire, Inc. All rights reserved.

/zigman2/quotes/202103251/composite
US : U.S.: Nasdaq
$ 42.55
-1.87 -4.21%
Volume: 746,476
May 24, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$4.73 billion
Rev. per Employee
$170,050
loading...

Partner Center

Link to MarketWatch's Slice.